SNT 6.25% 1.7¢ syntara limited

Is this imminent FDA feedback on the interim results from the...

  1. 437 Posts.
    lightbulb Created with Sketch. 7
    Is this imminent FDA feedback on the interim results from the mono therapy study or on the design protocol for the upcoming combined study with JAK inhibitor?
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
1.7¢
Change
0.001(6.25%)
Mkt cap ! $20.29M
Open High Low Value Volume
1.6¢ 1.7¢ 1.6¢ $1.248K 76.43K

Buyers (Bids)

No. Vol. Price($)
3 1214731 1.6¢
 

Sellers (Offers)

Price($) Vol. No.
1.7¢ 876421 8
View Market Depth
Last trade - 16.10pm 01/05/2024 (20 minute delay) ?
Last
1.7¢
  Change
0.001 ( 6.25 %)
Open High Low Volume
1.7¢ 1.7¢ 1.7¢ 24111
Last updated 15.59pm 01/05/2024 ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.